vigabatrin has been researched along with Hemisensory Neglect in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "From a group of 201 vigabatrin-exposed individuals with epilepsy, fourteen individuals were identified who were currently taking vigabatrin." | 3.79 | Evolution of visual field loss over ten years in individuals taking vigabatrin. ( Acheson, J; Clayton, LM; Newman, WD; Sander, JW; Sisodiya, SM; Stern, WM, 2013) |
| "Thirty three unselected patients attending neurology and epilepsy clinics were identified as taking vigabatrin and asked to attend for neuro-ophthalmic evaluation." | 3.70 | Visual field defects associated with vigabatrin therapy. ( Degg, C; Eke, T; Harding, GF; Lawden, MC; Wild, JM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayton, LM | 1 |
| Stern, WM | 1 |
| Newman, WD | 1 |
| Sander, JW | 1 |
| Acheson, J | 1 |
| Sisodiya, SM | 1 |
| Treiman, DM | 1 |
| Riikonen, R | 1 |
| Sorri, I | 1 |
| Brigell, MG | 1 |
| Mályusz, M | 1 |
| Mahlamäki, E | 1 |
| de Meynard, C | 1 |
| Kälviäinen, R | 1 |
| Acheson, JF | 1 |
| Lawden, MC | 1 |
| Eke, T | 1 |
| Degg, C | 1 |
| Harding, GF | 1 |
| Wild, JM | 1 |
6 other studies available for vigabatrin and Hemisensory Neglect
| Article | Year |
|---|---|
Evolution of visual field loss over ten years in individuals taking vigabatrin.
Topics: Adult; Anticonvulsants; Disease Progression; Epilepsy; Female; Humans; Longitudinal Studies; Male; M | 2013 |
Progressive vigabatrin-associated visual field loss and the importance of continuing assessment of risks and benefit of epilepsy treatments.
Topics: Anticonvulsants; Epilepsy; Humans; Perceptual Disorders; Vigabatrin; Visual Fields | 2013 |
Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life?
Topics: Adult; Anticonvulsants; Child; Disease Progression; Humans; Infant; Perceptual Disorders; Spasms, In | 2009 |
Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
Topics: 4-Aminobutyrate Transaminase; Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Female; gamma-Amin | 2010 |
Vigabatrin associated visual field constriction.
Topics: Anticonvulsants; Constriction, Pathologic; Electroretinography; Humans; Perceptual Disorders; Retina | 1999 |
Visual field defects associated with vigabatrin therapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Electrooculography; Electroretinography; Epilepsy; | 1999 |